Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -78.42% is 658% below its 5-year average of 14.05%, near the low end of its 5-year range (-78.42%–63.96%).
As of the fiscal period ended Tuesday, June 30, 2026. 259.08% below its 12-month average of -21.84%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -78.42%.
RETURN ON INVESTED CAPITAL (ROIC)
-78.42%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-21.84%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
49.19%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
14.05%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
-101.73%
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
-259.08%
CURRENT VS 3Y AVG
-259.42%
CURRENT VS 5Y AVG
-658.23%
CURRENT VS 10Y AVG
+22.91%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-33.50%
median of 663 covered companies
CURRENT VS SECTOR MEDIAN
-134.09%
vs the sector median at left
DarioHealth Corp.
Market Cap
$45.99M
Return on Invested Capital (ROIC)
-78.42%
TTM Avg
-21.84%
3Y Avg
49.19%
5Y Avg
14.05%
Market Cap
$44.50M
Return on Invested Capital (ROIC)
-80.92%
TTM Avg
33.73%
3Y Avg
-139.74%
5Y Avg
-139.74%
Market Cap
$44.26M
Return on Invested Capital (ROIC)
-127.36%
TTM Avg
-34.70%
3Y Avg
-36.91%
5Y Avg
-31.07%
Market Cap
$43.39M
Return on Invested Capital (ROIC)
-59.93%
TTM Avg
-52.27%
3Y Avg
-45.27%
5Y Avg
-36.51%
Market Cap
$45.22M
Return on Invested Capital (ROIC)
-156.97%
TTM Avg
-119.62%
3Y Avg
-76.34%
5Y Avg
-59.98%
Market Cap
$41.92M
Return on Invested Capital (ROIC)
-8.43%
TTM Avg
-19.61%
3Y Avg
-40.73%
5Y Avg
-42.38%
Market Cap
$41.78M
Return on Invested Capital (ROIC)
-72.12%
TTM Avg
-128.00%
3Y Avg
-128.00%
5Y Avg
-128.00%
Market Cap
$48.25M
Return on Invested Capital (ROIC)
-30.75%
TTM Avg
-66.28%
3Y Avg
-31.28%
5Y Avg
-35.56%
Market Cap
$48.05M
Return on Invested Capital (ROIC)
-14.57%
TTM Avg
-26.81%
3Y Avg
-19.60%
5Y Avg
-18.89%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| DarioHealth Corp. (DRIO) | $45.99M | -78.42% | -21.84% | 49.19% | 14.05% |
| BioStem Technologies, Inc. (BSEM)vs › | $44.50M | -80.92% | 33.73% | -139.74% | -139.74% |
| Nano-X Imaging Ltd. (NNOX)vs › | $44.26M | -127.36% | -34.70% | -36.91% | -31.07% |
| CVRx, Inc. (CVRX)vs › | $43.39M | -59.93% | -52.27% | -45.27% | -36.51% |
| Werewolf Therapeutics, Inc. (HOWL)vs › | $45.22M | -156.97% | -119.62% | -76.34% | -59.98% |
| Precipio, Inc. (PRPO)vs › | $41.92M | -8.43% | -19.61% | -40.73% | -42.38% |
| Filana Therapeutics, Inc. (FLNA)vs › | $41.78M | -72.12% | -128.00% | -128.00% | -128.00% |
| Lite Strategy, Inc. (LITS)vs › | $48.25M | -30.75% | -66.28% | -31.28% | -35.56% |
| Precision Optics Corporation, Inc. (POCI)vs › | $48.05M | -14.57% | -26.81% | -19.60% | -18.89% |
| Metagenomi, Inc. Common Stock (MGX)vs › | $39.92M | -66.03% | -39.70% | -29.53% | -27.72% |
ROIC
-78.4%
ROE
123.0%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -78.42% |
| 2026-03-31 | -56.57% |
| 2025-12-31 | -36.23% |
| 2025-09-30 | 19.10% |
| 2025-06-30 | 42.92% |
| 2025-03-31 | 46.19% |
| 2024-12-31 | 53.62% |
| 2024-09-30 | 60.43% |
| 2024-06-30 | 58.05% |
| 2024-03-31 | 50.06% |
| 2023-12-31 | 63.96% |
| 2023-09-30 | 51.81% |
| 2023-06-30 | 45.79% |
| 2023-03-31 | 53.90% |
| 2022-12-31 | 52.28% |
| 2022-09-30 | 22.76% |
| 2022-06-30 | -8.80% |
| 2022-03-31 | -40.53% |
| 2021-12-31 | -55.37% |
| 2021-09-30 | -33.63% |
| 2021-06-30 | -16.32% |
| 2021-03-31 | -4.84% |
| 2020-12-31 | -105.39% |
| 2020-09-30 | -70.89% |
| 2020-06-30 | -169.13% |
| 2020-03-31 | -139.50% |
| 2019-12-31 | -90.03% |
| 2019-09-30 | -426.07% |
| 2019-06-30 | -300.03% |
| 2019-03-31 | -456.99% |
| 2018-12-31 | -198.18% |
| 2018-09-30 | -150.32% |
| 2018-06-30 | -353.86% |
| 2018-03-31 | -177.64% |
| 2017-12-31 | -365.91% |
| 2017-09-30 | -247.52% |
| 2017-06-30 | -376.09% |
| 2017-03-31 | -410.40% |
| 2016-12-31 | -1172.23% |
| 2016-09-30 | -196.11% |
| 2016-06-30 | -125.10% |
| 2016-03-31 | -82.80% |
| 2015-12-31 | -227.28% |
| 2015-09-30 | -416.02% |
| 2015-06-30 | -873.41% |
| 2015-03-31 | -595.39% |
| 2014-12-31 | -775.29% |
| 2014-09-30 | -318.05% |
| 2014-06-30 | -809.42% |
| 2014-03-31 | -291.67% |
| 2013-12-31 | -519.70% |
| 2013-09-30 | -206.57% |
| 2013-06-30 | -115.00% |
| 2013-03-31 | -755.18% |
| 2012-12-31 | -227.28% |
